A novel Apigenin derivative suppresses renal cell carcinoma via directly inhibiting wild-type and mutant MET.
Li J, Tan G, Cai Y, Liu R, Xiong X, Gu B, He W, Liu B, Ren Q, Wu J, Chi B, Zhang H, Zhao Y, Xu Y, Zou Z, Kang F, Xu K.
Li J, et al.
Biochem Pharmacol. 2021 Aug;190:114620. doi: 10.1016/j.bcp.2021.114620. Epub 2021 May 24.
Biochem Pharmacol. 2021.
PMID: 34043966